Considerations for the Use of Biologic Agents in Patients With Chronic Rhinosinusitis With Nasal Polyposis

Article information

Clin Exp Otorhinolaryngol. 2021;14(4):435-435

Publication date (electronic) : 2021 November 15

doi : https://doi.org/10.21053/ceo.2021.02075

Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

See the letter "Considerations for the Use of Biologic Agents in Patients With Chronic Rhinosinusitis With Nasal Polyposis" on page 245.

Clinical and Experimental Otorhinolaryngology 2021;14:245-6.

https://doi.org/10.21053/ceo.2021.01249

The indication of the corresponding author was missing in the article. The corresponding author is as follows.

• Corresponding author: Sung Won Kim

Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea

Tel: +82-2-2258-6216, Fax: +82-2-535-1354

E-mail: kswent@catholic.ac.kr

Article information Continued

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.